Soligenix up 10% premarket on Fast Track for RiVax in U.S.

The FDA designates Soligenix’s (NASDAQ:SNGX) RiVax (heat stable ricin toxin vaccine) for Fast Track review for the prevention of ricin intoxication.

Fast Track status provides for more frequent interaction with the FDA review team and a rolling review of the marketing application.

Shares up 10% premarket on average volume.

https://seekingalpha.com/news/3541668-soligenix-up-10-premarket-on-fast-track-for-rivax-in-u-s